Biopharmaceutical Company BioVersys Plans Swiss Bourse IPO in Q1

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,443.00 GBX | +1.66% |
|
-1.54% | +7.17% |
Feb. 18 | GSK's Penmenvy Vaccine for Meningococcal Disease Gets US FDA Approval | MT |
Feb. 17 | FTSE 100 Starts Week in the Green as BAE Shares Take Flight | MT |